• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression.

作者信息

Read M A, Neish A S, Luscinskas F W, Palombella V J, Maniatis T, Collins T

机构信息

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

Immunity. 1995 May;2(5):493-506. doi: 10.1016/1074-7613(95)90030-6.

DOI:10.1016/1074-7613(95)90030-6
PMID:7538441
Abstract

Multiple cell adhesion proteins are up-regulated in vascular endothelial cells in response to TNF alpha and other inflammatory cytokines. This increase in cell adhesion gene expression is thought to require the transcription factor NF-kappa B. Here, we show that peptide aldehyde inhibitors of the proteasome, a multicatalytic protease recently shown to be required for the activation of NF-kappa B, block TNF alpha induction of the leukocyte adhesion molecules E-selectin, VCAM-1, and ICAM-1. Striking functional consequences of this inhibition were observed in analyses of leukocyte-endothelial interactions under defined flow conditions. Lymphocyte attachment to TNF alpha-treated endothelial monolayers was totally blocked, while neutrophil attachment was partially reduced but transmigration was essentially prevented.

摘要

相似文献

1
The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression.
Immunity. 1995 May;2(5):493-506. doi: 10.1016/1074-7613(95)90030-6.
2
Proteasome inhibitors block VCAM-1 and ICAM-1 gene expression in endothelial cells without affecting nuclear translocation of nuclear factor-kappa B.蛋白酶体抑制剂可阻断内皮细胞中血管细胞黏附分子-1(VCAM-1)和细胞间黏附分子-1(ICAM-1)的基因表达,而不影响核因子-κB的核转位。
Eur J Immunol. 1996 Apr;26(4):839-45. doi: 10.1002/eji.1830260417.
3
Effect of selective proteasome inhibitors on TNF-induced activation of primary and transformed endothelial cells.选择性蛋白酶体抑制剂对肿瘤坏死因子诱导的原代和转化内皮细胞活化的影响。
Am J Physiol. 1999 Apr;276(4):C856-64. doi: 10.1152/ajpcell.1999.276.4.C856.
4
A proteasome inhibitor reduces concurrent, sequential, and long-term IL-1 beta- and TNF-alpha-induced ECAM expression and adhesion.蛋白酶体抑制剂可降低白细胞介素-1β和肿瘤坏死因子-α同时、先后及长期诱导的细胞间黏附分子(ICAM)表达及黏附。
Am J Physiol Cell Physiol. 2003 Oct;285(4):C813-22. doi: 10.1152/ajpcell.00102.2003. Epub 2003 Jun 4.
5
Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells.血管细胞黏附分子-1(VCAM-1)基因的转录和表达通过一种对人类血管内皮细胞中抗氧化剂敏感的机制进行调控。
J Clin Invest. 1993 Oct;92(4):1866-74. doi: 10.1172/JCI116778.
6
Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression.类黄酮抑制细胞因子诱导的内皮细胞黏附蛋白基因表达。
Am J Pathol. 1995 Aug;147(2):278-92.
7
Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits.厚朴酚在体外可减弱肿瘤坏死因子-α处理的人主动脉内皮细胞中血管细胞黏附分子-1(VCAM-1)的表达,在体内可减弱高脂喂养兔主动脉中VCAM-1的表达。
Br J Pharmacol. 2002 Jan;135(1):37-47. doi: 10.1038/sj.bjp.0704458.
8
Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-kappa B.肿瘤坏死因子诱导的内皮细胞表面黏附分子的产生被蛋白酪氨酸磷酸酶抑制剂所阻断:核转录因子NF-κB的作用
Eur J Immunol. 1997 Sep;27(9):2172-9. doi: 10.1002/eji.1830270909.
9
Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.肿瘤坏死因子α通过激活核因子κB诱导人软骨样HCS-2/8细胞中基质降解相关基因的表达:蛋白酶体抑制剂可消除肿瘤坏死因子α的作用
J Bone Miner Res. 2001 Jul;16(7):1272-80. doi: 10.1359/jbmr.2001.16.7.1272.
10
Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor.蛋白酶体抑制剂和IkappaB超级阻遏物对活化大鼠肝星状细胞中NFkappaB的抑制作用
Hepatology. 1998 May;27(5):1285-95. doi: 10.1002/hep.510270514.

引用本文的文献

1
Adipose Tissue and Bone Marrow-Derived Mesenchymal Stem Cells are not Really the Same: Investigating the Differences in Their Immunomodulatory, Migratory, and Adhesive Profile.脂肪组织来源与骨髓来源的间充质干细胞并非完全相同:探究它们在免疫调节、迁移和黏附特性方面的差异
Biochem Genet. 2025 Feb;63(1):378-392. doi: 10.1007/s10528-024-10724-6. Epub 2024 Mar 5.
2
Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis: drug discovery and development of vascular cell adhesion molecule-1-directed novel therapeutics.靶向动脉粥样硬化内皮血管细胞黏附分子-1:血管细胞黏附分子-1 导向新型治疗药物的发现和开发。
Cardiovasc Res. 2023 Oct 24;119(13):2278-2293. doi: 10.1093/cvr/cvad130.
3
How Machine Perfusion Ameliorates Hepatic Ischaemia Reperfusion Injury.
机器灌注如何改善肝脏缺血再灌注损伤。
Int J Mol Sci. 2021 Jul 14;22(14):7523. doi: 10.3390/ijms22147523.
4
CD155 Promotes the Progression of Cervical Cancer Cells Through AKT/mTOR and NF-κB Pathways.CD155通过AKT/mTOR和NF-κB信号通路促进宫颈癌细胞进展
Front Oncol. 2021 Jun 7;11:655302. doi: 10.3389/fonc.2021.655302. eCollection 2021.
5
Role of liver sinusoidal endothelial cells in liver diseases.肝窦内皮细胞在肝脏疾病中的作用。
Nat Rev Gastroenterol Hepatol. 2021 Jun;18(6):411-431. doi: 10.1038/s41575-020-00411-3. Epub 2021 Feb 15.
6
Inhibition of BRD4 Reduces Neutrophil Activation and Adhesion to the Vascular Endothelium Following Ischemia Reperfusion Injury.BRD4 抑制减轻缺血再灌注损伤后中性粒细胞的活化和黏附于血管内皮。
Int J Mol Sci. 2020 Dec 17;21(24):9620. doi: 10.3390/ijms21249620.
7
Intercellular Mitochondrial Transfer in the Tumor Microenvironment.肿瘤微环境中的细胞间线粒体转移
Cancers (Basel). 2020 Jul 4;12(7):1787. doi: 10.3390/cancers12071787.
8
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.蛋白酶体作为一个具有多种治疗潜力的可药物靶标:有切与非切的两面性。
Pharmacol Ther. 2020 Sep;213:107579. doi: 10.1016/j.pharmthera.2020.107579. Epub 2020 May 19.
9
The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells.蛋白酶体抑制剂对多发性骨髓瘤细胞中端粒酶活性和调控的影响。
Int J Mol Sci. 2019 May 21;20(10):2509. doi: 10.3390/ijms20102509.
10
Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib.硼替佐米的临床药代动力学和药效学。
Clin Pharmacokinet. 2019 Feb;58(2):157-168. doi: 10.1007/s40262-018-0679-9.